Ann: Agreement for anticipated Aspiral China sales approx USD45M, page-197

Great work again @Relax1, it all looks very positive. Having an industry leader and influencer like iTest advocating MABR at the big expos and also taking technical teams from other organisations and groups on site visits is such a boon. It's all very well for WJY and our Fluence China salespeople to promote and recommend our tech as a solution to the industry, but when trusted established peers are doing it on our behalf - that must feel like a much more powerful, compelling, and - crucially - safer proposition to the listener. As ever, looking forward to confirmation of orders to validate this interest - but I wouldn't even have this information about potential progress if not for the brilliant and generous research posted here. Thanks again, it genuinely is appreciated.

This is an amazing niche for us, the service area / expressway market. I don't recall it ever being spoken about on here prior to the first iTest plant, but then that announcement was like a lightbulb moment. It's a perfect environment for Aspiral. That this niche commercial sector is embracing it, even in this tentative/limited way for now, provides great encouragement that not only other private markets (the classic examples of hotels, resorts, golf clubs etc) will eventually embrace it, but that the slower public municipal market will too. Sticking with expressway-management for now though, Barry has asked what everyone is thinking. How big does this niche get? No doubt you have the detail, but even to the less-well-researched eye such as mine I feel that it could be transformational if we were able to make our bones as the dominant tech in this niche of China's infrastructure build-out. First in Hubei, then inter-provincially, then perhaps one day even internationally.

#patience